Effect of Haptic Cueing on Long-Range Autocorrelations in Parkinson's Disease Gait Variability (NCT05790759) | Clinical Trial Compass
CompletedNot Applicable
Effect of Haptic Cueing on Long-Range Autocorrelations in Parkinson's Disease Gait Variability
Belgium10 participantsStarted 2020-01-01
Plain-language summary
Parkinson's Disease (PD) patients suffer from gait impairments responsible for falls and bad quality of life: reduced speed and stride length, randomness in the temporal organization of stride duration variability (reduced Long-Range Autocorrelations (LRA)). For years, auditory cueing has been used to modulate PD gait and its effect on LRA is known. Less is known regarding the effects of haptic cueing on PD gait and especially on LRA. This pilot study will compare the spatio-temporal gait parameters and LRA of PD patients tested under three conditions: walking without cueing, walking with auditory cueing and walking with haptic cueing by means of rhythmic vibrations on the patients' wrists.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Idiopathic PD according to the UK Brain Bank Criteria
* modified Hoehn \& Yahr scale \<= 3
* Mini-Mental State Examination \> 24/30
* Ability to walk 256 consecutive strides
Exclusion Criteria:
* Other pathology interacting with gait
* Significant hearing problems not allowing to hear the auditory cueing
* Significant somatosensory problems not allowing to feel the haptic cueing on the skin
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Long-Range Autocorrelations
Timeframe: Change from baseline in long-range autocorrelations during each intervention condition (3 x 10 min walking)
Trial details
NCT IDNCT05790759
SponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain